Cytokine mRNA expression in patients with multiple sclerosis and fatigue

被引:124
作者
Flachenecker, P
Bihler, I
Weber, F
Gottschalk, M
Toyka, KV
Rieckmann, P
机构
[1] Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany
[2] Max Planck Inst Psychiat, Neurol Sect, D-80804 Munich, Germany
关键词
autonomic dysfunction; cytokines; fatigue; multiple sclerosis; RNA; messenger;
D O I
10.1191/1352458504ms991oa
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Fatigue is one of the most common disabling symptoms in patients with multiple sclerosis ( MS), but the putative role of proinflammatory cytokines remains to be elucidated. Methods: Thirty-seven patients ( 27 women, 10 men) with relapsing - remitting ( n = 29) and secondary progressive ( n = 8) MS, aged 41.0 +/- 10.2 years, were studied. Fatigue was assessed by Krupp's Fatigue Severity Scale (FSS). Cytokine mRNA expression for interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha and interleukin (IL)-10 were measured by real time RT PCR. Autonomic function was evaluated by standard tests for parasympathetic and sympathetic function, as well as by serum levels of norepinephrine and epinephrine. Results: Median levels of TNF-alpha mRNA expression were significantly higher in MS patients with (FSS greater than or equal to 4.0 and greater than or equal to 5.0, n = 26 and n = 14, respectively) than in those without fatigue (FSS < 4.0, n = 11). No differences were seen for IFN-gamma and IL-10 mRNA expression. Cytokine levels were not correlated to autonomic tests or to serum catecholamine levels. Conclusions: These results suggest that TNF-alpha, as a principal pro inflammatory mediator, is associated with MS-related fatigue. This is in support of a pathogenic role of the MS-related inflammatory pro cess in the development of fatigue.
引用
收藏
页码:165 / 169
页数:5
相关论文
共 38 条
[1]  
[Anonymous], 1999, Neurology, V53, P457
[2]   Fatigue in multiple sclerosis and its relationship to depression and neurologic disability [J].
Bakshi, R ;
Shaikh, ZA ;
Miletich, RS ;
Czarnecki, D ;
Dmochowski, J ;
Henschel, K ;
Janardhan, V ;
Dubey, N ;
Kinkel, PR .
MULTIPLE SCLEROSIS JOURNAL, 2000, 6 (03) :181-185
[3]  
BERTOLONE K, 1993, NEUROLOGY, V43, pA356
[4]   Fatigue and proinflammatory cytokine activity in breast cancer survivors [J].
Bower, JE ;
Ganz, PA ;
Aziz, N ;
Fahey, JL .
PSYCHOSOMATIC MEDICINE, 2002, 64 (04) :604-611
[5]  
Branas P., 2000, HEALTH TECHNOL ASSES, V4, P1, DOI [10.3310/hta4270, DOI 10.3310/HTA4270]
[6]   Physiopathology and treatment of fatigue in multiple sclerosis [J].
Comi, G ;
Leocani, L ;
Rossi, P ;
Colombo, B .
JOURNAL OF NEUROLOGY, 2001, 248 (03) :174-179
[7]   Fatigue in MS is related to sympathetic vasomotor dysfunction [J].
Flachenecker, P ;
Rufer, A ;
Bihler, I ;
Hippel, C ;
Reiners, K ;
Toyka, KV ;
Kesselring, J .
NEUROLOGY, 2003, 61 (06) :851-853
[8]   Fatigue in multiple sclerosis:: a comparison of different rating scales and correlation to clinical parameters [J].
Flachenecker, P ;
Kümpfel, T ;
Kallmann, B ;
Gottschalk, M ;
Grauer, O ;
Rieckmann, P ;
Trenkwalder, C ;
Toyka, K .
MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (06) :523-526
[9]   Cardiovascular autonomic dysfunction in multiple sclerosis: correlation with orthostatic intolerance [J].
Flachenecker, P ;
Wolf, A ;
Krauser, M ;
Hartung, HP ;
Reiners, K .
JOURNAL OF NEUROLOGY, 1999, 246 (07) :578-586
[10]   Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability [J].
Flachenecker, P ;
Reiners, K ;
Krauser, M ;
Wolf, A ;
Toyka, KV .
MULTIPLE SCLEROSIS, 2001, 7 (05) :327-334